Else Nutrition Holdings Inc. (CSE:BABY)
Canada · Delayed Price · Currency is CAD | Market Cap | 861.21K -87.3% |
| Revenue (ttm) | 5.41M -31.8% |
| Net Income | -6.00M |
| EPS | -1.56 |
| Shares Out | 8.20M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Open | 0.1050 |
| Previous Close | 0.1050 |
| Day's Range | 0.1050 - 0.1050 |
| 52-Week Range | 0.0700 - 4.0000 |
| Beta | 0.95 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 28, 2026 |
About Else Nutrition Holdings
Else Nutrition Holdings Inc. focuses on the research, development, manufacturing, marketing, and sale of plant-based food and nutrition products for infants, toddlers, children, and adults in Israel. The company provides baby snacks; baby feeding accessories comprising feeding bottles and teats; infant formula with plant-based nutrition for babies and toddlers; nutrition products for toddlers, children, and adults; complementary food products; and drinks for toddlers. It offers its products online. The company was founded in 2012 and is headqua... [Read more]
Financial Performance
In 2025, Else Nutrition Holdings's revenue was 6.03 million, a decrease of -24.43% compared to the previous year's 7.97 million. Losses were -8.88 million, -41.51% less than in 2024.
Financial StatementsNews
Else Nutrition Confirms Trading on a Post-Consolidation Basis
VANCOUVER, BC, July 8, 2026 /PRNewswire/ - ELSE NUTRITION HOLDINGS INC. (CSE: BABY) (OTCQX: BABYF) (FSE: 0YL) (the "Company"), further to its news release dated July 7, 2026, confirms that following t...
Else Nutrition Announces CSE Listing and Consolidation
VANCOUVER, BC, July 7, 2026 /PRNewswire/ - ELSE NUTRITION HOLDINGS INC. (CSE: BABY) (OTCQX: BABYF) (FSE: 0YL) (the "Company") announces that it has completed the previously announced consolidation of ...
Else Nutrition Announces CSE Conditional Approval
VANCOUVER, BC, June 29, 2026 /PRNewswire/ - ELSE NUTRITION HOLDINGS INC. (TSX: BABY) (OTCQX: BABYF) (FSE: 0YL) (the "Company") is pleased to announce that it has received conditional approval to list ...
Else Nutrition kicks off a Manufacturing Drive in Q2 2026
Expects to improve product supply and meet growing consumer demand in the US and Canada VANCOUVER, BC, June 1, 2026 /PRNewswire/ - ELSE NUTRITION HOLDINGS INC. (TSX: BABY) (OTCQX: BABYF) (FSE: 0YL.F) ...
Else Nutrition Reports First Quarter 2026 Results Highlighting Significant Improvement in Gross Margin and Reduced Net Loss
VANCOUVER, BC, May 15, 2026 /PRNewswire/ - ELSE NUTRITION HOLDINGS INC. ( BABY) ( BABYF) ( 0YL.F) ("Else" or the "Company"), today reported financial results for the 2026 first quarter ended March ...
Else Nutrition Holdings Registration statement: Q1 2026
Else Nutrition Holdings filed a registration statement on May 15, 2026, providing details about a securities offering with the SEC.
Else Nutrition Holdings Registration statement: Q1 2026
Else Nutrition Holdings filed a registration statement on May 15, 2026, providing details about a securities offering with the SEC.
Else Nutrition Holdings Earnings release: Q1 2026
Else Nutrition Holdings released its Q1 2026 earnings on May 15, 2026, summarizing the period's financial results.
Else Nutrition Commends Trump Administration's Expanded Commitment to Bolstering Infant Formulas Regulation in FY2027
President's Budget requested significant FDA funding increases, signaling growing support for Else's next-generation plant-based infant formula Builds Upon FY26 Congressional Appropriations Directive ...
Else Nutrition Holdings Earnings release: Q4 2025
Else Nutrition Holdings released its Q4 2025 earnings on March 31, 2026, summarizing the period's financial results.
Else Nutrition Holdings Registration statement: Q4 2025
Else Nutrition Holdings filed a registration statement on March 31, 2026, providing details about a securities offering with the SEC.
Else Nutrition Holdings Registration statement: Q4 2025
Else Nutrition Holdings filed a registration statement on March 31, 2026, providing details about a securities offering with the SEC.
Else Nutrition Holdings Document: Q4 2025
Else Nutrition Holdings filed a regulatory document on March 31, 2026 disclosing important business information.
Else Nutrition Holdings Transcript: Investor Summit Virtual Conference
A pioneering plant-based infant nutrition provider highlighted its financial turnaround, regulatory breakthroughs, and strong market positioning. FDA engagement and legislative changes are paving the way for potential U.S. approval, with profitability targeted by early 2027.
Else Nutrition Expected to Benefit from FDA Regulatory Progress on Infant Formula Protein Standards
Updated FDA Framework Bolsters Scientific Validation Pathway for Else's Plant‑Based Formula and Accelerates U.S. Commercialization Potential VANCOUVER, BC, March 10, 2026 /PRNewswire/ - ELSE NUTRITION...
Else Nutrition Surpasses One Million Cans Sold Since Launch
Milestone underscores accelerating consumer demand for clean, dairy-free nutrition alternatives VANCOUVER, BC, Jan. 29, 2026 /PRNewswire/ - ELSE NUTRITION HOLDINGS INC. (TSX: BABY) (OTC: BABYF) (FS...
Else Nutrition Announces Results from Annual General Meeting of Shareholders
VANCOUVER, BC, Jan. 12, 2026 /PRNewswire/ - ELSE NUTRITION HOLDINGS INC. (TSX: BABY) (OTCQX: BABYF) (FSE: 0YL) (the "Company") announces that at its annual general meeting of shareholders held on Dece...
Else Nutrition Plans Canadian Market Relaunch in 2026
Strategic Re-Entry Expected to Generate CAD$500,000 in Initial-Year Revenue VANCOUVER, BC, Jan. 7, 2026 /PRNewswire/ - ELSE NUTRITION HOLDINGS INC. ( BABY) ( BABYF) (0YL0) ("Else" or the "Company")...
Else Nutrition Announces Appointment of Natie Zilberberg as Chief Financial Officer
VANCOUVER, BC, Jan. 5, 2026 /PRNewswire/ - ELSE NUTRITION HOLDINGS INC. (TSX: BABY) (OTC: BABYF) (FSE: 0YL) (the "Company") is pleased to announce that it has appointed Natie Zilberberg as the Chief F...
Else Nutrition Achieves Transformative Operational and Financial Progress in 2025
Poised to Enter 2026 with Strengthened Momentum, FDA Breakthrough for a Clear Approval Pathway, and a Streamlined Path Toward Cash-Flow Breakeven VANCOUVER, BC , Dec. 17, 2025 /PRNewswire/ - ELSE NUTR...
ELSE NUTRITION ANNOUNCES FURTHER EXTENSION OF ANNUAL GENERAL MEETING OF SHAREHOLDERS
VANCOUVER, BC , Dec. 12, 2025 /PRNewswire/ - ELSE NUTRITION HOLDINGS INC. (TSX: BABY) (OTCPINK: BABYF) (FSE: 0YL) (the "Company") announces that further to its news releases dated June 19, 2025 and Au...
Else Nutrition CEO to Present at Investor Summit Virtual on December 9, 2025
VANCOUVER, BC / ACCESS Newswire / December 4, 2025 / ELSE NUTRITION HOLDINGS INC. (TSX: BABY)(OTC PINK: BABYD) ("Else" or the "Company"), a global pioneer in whole-food, plant-based nutrition for ba...
Else Nutrition Secures Five-Year Renewal of Israel's Largest Health Fund Tender for Baby Feeding Solutions
Winning Five-Year Health Tender Reinforces Else's Leadership in Hospital-Grade Infant Feeding Accessories VANCOUVER, BC , Dec. 2, 2025 /PRNewswire/ - Else Nutrition Holdings Inc. (TSX: BABY) (OTC: BAB...
Else Nutrition Announces Major Breakthrough: President Trump Signs Pivotal FDA Funding Package that Includes Congressional Directive Streamlining Regulatory Pathway for Non-Dairy, Non-Soy Plant-Based Infant Formula
New Federal Budget Agreement Ends Government Shutdown and Expedites FDA Pathway for Innovative, Non-Soy, Plant-Based Infant Nutrition Under Operation Stork Speed VANCOUVER, BC , Nov. 18, 2025 /PRNewsw...
Else Nutrition Holdings Earnings Call Transcript: Q3 2025
Gross margin surged to 34% in Q3 2025, with operating expenses down 68% year-over-year and monthly cash burn below $200,000. Revenue dipped due to temporary supply issues, but demand remains strong and the company targets cash flow break-even by late 2026 to early 2027.